ACETNasdaqPharmaceutical PreparationsFiscal year ends December 26
Adicet Bio, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026
$4.53−0.04 (-0.88%)
Close on Oct 19, 2026
- Market cap
- $48.68M
- P/E (TTM)
- –
- Dividend yield
- –
Price history
Daily open, high, low, close and volume
| Date | Open | High | Low | Close | Change | Volume |
|---|---|---|---|---|---|---|
| Daily prices are not in StockData yet. This table fills in once an end-of-day price source is connected. | ||||||
Stock splits
From SEC filings
| Date | Ratio | Effect on per-share figures |
|---|---|---|
| Mar 12, 2026(first seen in filings) | 1-for-16 reverse | Earlier per-share figures multiplied by 16 |
| Dec 30, 2025 | 1-for-16 reverse | Earlier per-share figures multiplied by 16 |
| Nov 5, 2020(first seen in filings) | 1-for-16.67 reverse | Earlier per-share figures multiplied by 16.6667 |
| Sep 16, 2020 | 1-for-7 reverse | Earlier per-share figures multiplied by 7 |